Replay is genome writing company reprogramming biology by writing and delivering big DNA
Replay has raised €54M across 1 funding round from 7 investors, most recently a Seed round in Jul 2022. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-26 | Seed | €54M |
| Artis Ventures,Axial,DeciBio Ventures,KKR,Lansdowne Partners,OMX Ventures+1 more |
| View deal → |
